Prostate cancer is one of the most prominent cancers diagnosed in males. Contrasting with other cancer types, glucose utilization is not increased in prostate carcinoma cells as they employ different metabolic adaptations involving mitochondria as a source of energy and intermediates required for rapid cell growth. In this regard, prostate cancer cells were associated with higher activity of mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH), the key rate limiting component of the glycerophosphate shuttle, which connects mitochondrial and cytosolic processes and plays significant role in cellular bioenergetics. Our research focused on the role of mGPDH biogenesis and regulation in prostate cancer compared to healthy cells. We show that the 42 amino acid presequence is cleaved from N-terminus during mGPDH biogenesis. Only the processed form is part of the mGPDH dimer that is the prominent functional enzyme entity. We demonstrate that mGPDH overexpression enhances the wound healing ability in prostate cancer cells. As mGPDH is at the crossroad of glycolysis, lipogenesis and oxidative metabolism, regulation of its activity by intramitochondrial processing might represent rapid means of cellular metabolic adaptations.

Department of Bioenergetics Institute of Physiology Czech Academy of Sciences Videnska 1083 142 20 Prague Czech Republic

Zobrazit více v PubMed

Culp M.B., Soerjomataram I., Efstathiou J.A., Bray F., Jemal A. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. Eur. Urol. 2020;77:38–52. doi: 10.1016/j.eururo.2019.08.005. PubMed DOI

Pavlova N.N., Thompson C.B. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016;23:27–47. doi: 10.1016/j.cmet.2015.12.006. PubMed DOI PMC

Cutruzzola F., Giardina G., Marani M., Macone A., Paiardini A., Rinaldo S., Paone A. Glucose Metabolism in the Progression of Prostate Cancer. Front. Physiol. 2017;8:97. doi: 10.3389/fphys.2017.00097. PubMed DOI PMC

Costello L.C., Franklin R.B., Feng P. Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer. Mitochondrion. 2005;5:143–153. doi: 10.1016/j.mito.2005.02.001. PubMed DOI PMC

Singh K.K., Desouki M.M., Franklin R.B., Costello L.C. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol. Cancer. 2006;5:14. doi: 10.1186/1476-4598-5-14. PubMed DOI PMC

Gonthier K., Poluri R.T.K., Audet-Walsh E. Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer. J. Steroid Biochem. Mol. Biol. 2019;191:105367. doi: 10.1016/j.jsbmb.2019.04.016. PubMed DOI

DeBerardinis R.J., Lum J.J., Hatzivassiliou G., Thompson C.B. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11–20. doi: 10.1016/j.cmet.2007.10.002. PubMed DOI

Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. PubMed DOI

Jia D., Park J.H., Jung K.H., Levine H., Kaipparettu B.A. Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States. Cells. 2018;7 doi: 10.3390/cells7030021. PubMed DOI PMC

Stoykova G.E., Schlaepfer I.R. Lipid Metabolism and Endocrine Resistance in Prostate Cancer, and New Opportunities for Therapy. Int. J. Mol. Sci. 2019;20 doi: 10.3390/ijms20112626. PubMed DOI PMC

Bader D.A., Hartig S.M., Putluri V., Foley C., Hamilton M.P., Smith E.A., Saha P.K., Panigrahi A., Walker C., Zong L., et al. Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer. Nat. Metab. 2019;1:70–85. doi: 10.1038/s42255-018-0002-y. PubMed DOI PMC

Bajpai P., Koc E., Sonpavde G., Singh R., Singh K.K. Mitochondrial localization, import, and mitochondrial function of the androgen receptor. J. Biol. Chem. 2019;294:6621–6634. doi: 10.1074/jbc.RA118.006727. PubMed DOI PMC

Dueregger A., Schopf B., Eder T., Hofer J., Gnaiger E., Aufinger A., Kenner L., Perktold B., Ramoner R., Klocker H., et al. Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate. PLoS ONE. 2015;10:e0135704. doi: 10.1371/journal.pone.0135704. PubMed DOI PMC

Pertega-Gomes N., Felisbino S., Massie C.E., Vizcaino J.R., Coelho R., Sandi C., Simoes-Sousa S., Jurmeister S., Ramos-Montoya A., Asim M., et al. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: A role for monocarboxylate transporters as metabolic targets for therapy. J. Pathol. 2015;236:517–530. doi: 10.1002/path.4547. PubMed DOI PMC

Schlaepfer I.R., Rider L., Rodrigues L.U., Gijon M.A., Pac C.T., Romero L., Cimic A., Sirintrapun S.J., Glode L.M., Eckel R.H., et al. Lipid catabolism via CPT1 as a therapeutic target for prostate cancer. Mol. Cancer Ther. 2014;13:2361–2371. doi: 10.1158/1535-7163.MCT-14-0183. PubMed DOI PMC

Schopf B., Weissensteiner H., Schafer G., Fazzini F., Charoentong P., Naschberger A., Rupp B., Fendt L., Bukur V., Giese I., et al. OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation. Nat. Commun. 2020;11:1487. doi: 10.1038/s41467-020-15237-5. PubMed DOI PMC

Chowdhury S.K., Gemin A., Singh G. High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines. Biochem. Biophys. Res. Commun. 2005;333:1139–1145. doi: 10.1016/j.bbrc.2005.06.017. PubMed DOI

Chowdhury S.K., Raha S., Tarnopolsky M.A., Singh G. Increased expression of mitochondrial glycerophosphate dehydrogenase and antioxidant enzymes in prostate cancer cell lines/cancer. Free Radic. Res. 2007;41:1116–1124. doi: 10.1080/10715760701579314. PubMed DOI

Mracek T., Drahota Z., Houstek J. The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues. Biochim. Biophys. Acta. 2013;1827:401–410. doi: 10.1016/j.bbabio.2012.11.014. PubMed DOI

Drahota Z., Chowdhury S.K., Floryk D., Mracek T., Wilhelm J., Rauchova H., Lenaz G., Houstek J. Glycerophosphate-dependent hydrogen peroxide production by brown adipose tissue mitochondria and its activation by ferricyanide. J. Bioenerg. Biomembr. 2002;34:105–113. doi: 10.1023/A:1015123908918. PubMed DOI

Mracek T., Pecinova A., Vrbacky M., Drahota Z., Houstek J. High efficiency of ROS production by glycerophosphate dehydrogenase in mammalian mitochondria. Arch. Biochem. Biophys. 2009;481:30–36. doi: 10.1016/j.abb.2008.10.011. PubMed DOI

Bell R.M., Coleman R.A. Enzymes of glycerolipid synthesis in eukaryotes. Annu. Rev. Biochem. 1980;49:459–487. doi: 10.1146/annurev.bi.49.070180.002331. PubMed DOI

Hunt S.M., Osnos M., Rivlin R.S. Thyroid hormone regulation of mitochondrial alpha-glycerophosphate dehydrogenase in liver and hepatoma. Cancer Res. 1970;30:1764–1768. PubMed

Pedersen P.L. Tumor mitochondria and the bioenergetics of cancer cells. Prog. Exp. Tumor. Res. 1978;22:190–274. doi: 10.1159/000401202. PubMed DOI

Schagger H. Tricine-SDS-PAGE. Nat. Protoc. 2006;1:16–22. doi: 10.1038/nprot.2006.4. PubMed DOI

Wittig I., Karas M., Schagger H. High resolution clear native electrophoresis for in-gel functional assays and fluorescence studies of membrane protein complexes. Mol. Cell. Proteom. 2007;6:1215–1225. doi: 10.1074/mcp.M700076-MCP200. PubMed DOI

Frederiks W.M., Marx F., Myagkaya G.L. A histochemical study of changes in mitochondrial enzyme activities of rat liver after ischemia in vitro. Virchows Arch. B. 1986;51:321–329. doi: 10.1007/BF02899041. PubMed DOI

Mracek T., Jesina P., Krivakova P., Bolehovska R., Cervinkova Z., Drahota Z., Houstek J. Time-course of hormonal induction of mitochondrial glycerophosphate dehydrogenase biogenesis in rat liver. Biochim. Biophys. Acta. 2005;1726:217–223. doi: 10.1016/j.bbagen.2005.06.011. PubMed DOI

Hartmannova H., Piherova L., Tauchmannova K., Kidd K., Acott P.D., Crocker J.F., Oussedik Y., Mallet M., Hodanova K., Stranecky V., et al. Acadian variant of Fanconi syndrome is caused by mitochondrial respiratory chain complex I deficiency due to a non-coding mutation in complex I assembly factor NDUFAF6. Hum. Mol. Genet. 2016;25:4062–4079. doi: 10.1093/hmg/ddw245. PubMed DOI

Tyanova S., Temu T., Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 2016;11:2301–2319. doi: 10.1038/nprot.2016.136. PubMed DOI

Pajuelo Reguera D., Cunatova K., Vrbacky M., Pecinova A., Houstek J., Mracek T., Pecina P. Cytochrome c Oxidase Subunit 4 Isoform Exchange Results in Modulation of Oxygen Affinity. Cells. 2020;9 doi: 10.3390/cells9020443. PubMed DOI PMC

Mracek T., Pecina P., Vojtiskova A., Kalous M., Sebesta O., Houstek J. Two components in pathogenic mechanism of mitochondrial ATPase deficiency: Energy deprivation and ROS production. Exp. Gerontol. 2006;41:683–687. doi: 10.1016/j.exger.2006.02.009. PubMed DOI

Bentlage H.A., Wendel U., Schagger H., ter Laak H.J., Janssen A.J., Trijbels J.M. Lethal infantile mitochondrial disease with isolated complex I deficiency in fibroblasts but with combined complex I and IV deficiencies in muscle. Neurology. 1996;47:243–248. doi: 10.1212/WNL.47.1.243. PubMed DOI

Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2:329–333. doi: 10.1038/nprot.2007.30. PubMed DOI

Feng C., Wee W.K., Chen H., Ong L.T., Qu J., Tan H.F., Tan S.M. Expression of kindlin-3 in melanoma cells impedes cell migration and metastasis. Cell Adhes. Migr. 2017;11:419–433. doi: 10.1080/19336918.2016.1243645. PubMed DOI PMC

UniProt C. UniProt: A worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47:D506–D515. doi: 10.1093/nar/gky1049. PubMed DOI PMC

Kall L., Krogh A., Sonnhammer E.L. A combined transmembrane topology and signal peptide prediction method. J. Mol. Biol. 2004;338:1027–1036. doi: 10.1016/j.jmb.2004.03.016. PubMed DOI

Compute pI/MW Tool. [(accessed on 8 June 2020)]; Available online: https://web.expasy.org/compute_pi/

Lu B., Poirier C., Gaspar T., Gratzke C., Harrison W., Busija D., Matzuk M.M., Andersson K.E., Overbeek P.A., Bishop C.E. A mutation in the inner mitochondrial membrane peptidase 2-like gene (Immp2l) affects mitochondrial function and impairs fertility in mice. Biol. Reprod. 2008;78:601–610. doi: 10.1095/biolreprod.107.065987. PubMed DOI

Yuan L., Zhai L., Qian L., Huang D., Ding Y., Xiang H., Liu X., Thompson J.W., Liu J., He Y.H., et al. Switching off IMMP2L signaling drives senescence via simultaneous metabolic alteration and blockage of cell death. Cell Res. 2018;28:625–643. doi: 10.1038/s41422-018-0043-5. PubMed DOI PMC

Schmidt O., Pfanner N., Meisinger C. Mitochondrial protein import: From proteomics to functional mechanisms. Nat. Rev. Mol. Cell Biol. 2010;11:655–667. doi: 10.1038/nrm2959. PubMed DOI

Jadvar H., Desai B., Ji L., Conti P.S., Dorff T.B., Groshen S.G., Pinski J.K., Quinn D.I. Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer. J. Nucl. Med. 2013;54:1195–1201. doi: 10.2967/jnumed.112.114116. PubMed DOI PMC

Elia I., Schmieder R., Christen S., Fendt S.M. Organ-Specific Cancer Metabolism and Its Potential for Therapy. Handb. Exp. Pharmacol. 2016;233:321–353. doi: 10.1007/164_2015_10. PubMed DOI

Quinlan C.L., Perevoshchikova I.V., Hey-Mogensen M., Orr A.L., Brand M.D. Sites of reactive oxygen species generation by mitochondria oxidizing different substrates. Redox Biol. 2013;1:304–312. doi: 10.1016/j.redox.2013.04.005. PubMed DOI PMC

Koza R.A., Kozak U.C., Brown L.J., Leiter E.H., MacDonald M.J., Kozak L.P. Sequence and tissue-dependent RNA expression of mouse FAD-linked glycerol-3-phosphate dehydrogenase. Arch. Biochem. Biophys. 1996;336:97–104. doi: 10.1006/abbi.1996.0536. PubMed DOI

Thakur S., Daley B., Gaskins K., Vasko V.V., Boufraqech M., Patel D., Sourbier C., Reece J., Cheng S.Y., Kebebew E., et al. Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo. Clin. Cancer Res. 2018;24:4030–4043. doi: 10.1158/1078-0432.CCR-17-3167. PubMed DOI PMC

Houstek J., Drahota Z. The regulation of glycerol 3-phosphate oxidase of rate brownadipose tissue mitochondria by long-chain free fatty acids. Mol. Cell. Biochem. 1975;7:45–50. doi: 10.1007/BF01732162. PubMed DOI

Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P. Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain. J. Proteome Res. 2008;7:311–318. doi: 10.1021/pr0701254. PubMed DOI

DeNardo B.D., Holloway M.P., Ji Q., Nguyen K.T., Cheng Y., Valentine M.B., Salomon A., Altura R.A. Quantitative phosphoproteomic analysis identifies activation of the RET and IGF-1R/IR signaling pathways in neuroblastoma. PLoS ONE. 2013;8:e82513. doi: 10.1371/journal.pone.0082513. PubMed DOI PMC

MacPherson L., Tokatlidis K. Protein trafficking in the mitochondrial intermembrane space: Mechanisms and links to human disease. Biochem. J. 2017;474:2533–2545. doi: 10.1042/BCJ20160627. PubMed DOI PMC

Yeh J.I., Chinte U., Du S. Structure of glycerol-3-phosphate dehydrogenase, an essential monotopic membrane enzyme involved in respiration and metabolism. Proc. Natl. Acad. Sci. USA. 2008;105:3280–3285. doi: 10.1073/pnas.0712331105. PubMed DOI PMC

Allen K.N., Entova S., Ray L.C., Imperiali B. Monotopic Membrane Proteins Join the Fold. Trends Biochem. Sci. 2019;44:7–20. doi: 10.1016/j.tibs.2018.09.013. PubMed DOI PMC

Krogh A., Larsson B., von Heijne G., Sonnhammer E.L. Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes. J. Mol. Biol. 2001;305:567–580. doi: 10.1006/jmbi.2000.4315. PubMed DOI

Sonnhammer E.L., von Heijne G., Krogh A. A hidden Markov model for predicting transmembrane helices in protein sequences. Proc. Int Conf. Intell Syst. Mol. Biol. 1998;6:175–182. PubMed

TMpred. [(accessed on 8 June 2020)]; Available online: https://embnet.vital-it.ch/software/TMPRED_form.html.

Bharadwaj M.S., Zhou Y., Molina A.J., Criswell T., Lu B. Examination of bioenergetic function in the inner mitochondrial membrane peptidase 2-like (Immp2l) mutant mice. Redox Biol. 2014;2:1008–1015. doi: 10.1016/j.redox.2014.08.006. PubMed DOI PMC

Mracek T., Holzerova E., Drahota Z., Kovarova N., Vrbacky M., Jesina P., Houstek J. ROS generation and multiple forms of mammalian mitochondrial glycerol-3-phosphate dehydrogenase. Biochim. Biophys. Acta. 2014;1837:98–111. doi: 10.1016/j.bbabio.2013.08.007. PubMed DOI

Denisenko T.V., Gorbunova A.S., Zhivotovsky B. Mitochondrial Involvement in Migration, Invasion and Metastasis. Front. Cell Dev. Biol. 2019;7:355. doi: 10.3389/fcell.2019.00355. PubMed DOI PMC

Lehuede C., Dupuy F., Rabinovitch R., Jones R.G., Siegel P.M. Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis. Cancer Res. 2016;76:5201–5208. doi: 10.1158/0008-5472.CAN-16-0266. PubMed DOI

Orr A.L., Ashok D., Sarantos M.R., Ng R., Shi T., Gerencser A.A., Hughes R.E., Brand M.D. Novel inhibitors of mitochondrial sn-glycerol 3-phosphate dehydrogenase. PLoS ONE. 2014;9:e89938. doi: 10.1371/journal.pone.0089938. PubMed DOI PMC

Genetic Complementation of ATP Synthase Deficiency Due to Dysfunction of TMEM70 Assembly Factor in Rat